APN-431

N/A

Report date: 2025/01/02 16:11:23
NME

Base Information

Drug NameAPN-431
Drug Alias NameAPN-431APN431
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionE3 ubiquitin-protein ligase CBL-B expression inhibitors
TargetsE3 ubiquitin-protein ligase CBL-B
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDomainex Ltd
China Registration ClassN/A

Develop Information

Active CompaniesApeiron BiologicsDomainex Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A